By downregulating MAPK14 in renal cancer cells lines using a 2-Furanone compound called “compound 3a”, Abd El-Hameed et al. [41] showed that these have promising anticancer activities and corroborrate our suggestion that MAPK14 could be a very promising target against kidney cancer. This evidence concerns the gene MAPK14 and kidney cancer.